Michael Jaharis is an American businessman who has a net worth of $2.2 billion. Best known as the founder of Kos Pharmaceuticals and Vatera Healthcare Partners, Michael Jaharis is also one of the co-founders of Arisaph Pharmaceuticals. Upon his graduation from Carroll University and DePaul University where he completed his PhD, Michael Jaharis started his professional career at Miles Laboratories, working from 1961 through 1972.
Since 1972, he landed the position of CEO and President of Key Pharmaceuticals until its merger with Schering-Plough Corporation more than a decade later. In 1988, Jaharis decided to found Kos Pharmaceuticals, Inc, the company that introduced Niaspan, a cholesterol-fighting drug that was later sold to Abbott Labs for $4.2 billion. Furthermore, Michael Jaharis established himself as a great philanthropist who has made generous contributions to various organizations like Weill Cornell Medical College of Cornell University, the Art Institute of Chicago, the Metropolitan Museum of Art and the Metropolitan Opera, as well as the Tufts University School of Medicine and the Columbia University Medical Center.
| Net Worth: | $2.2 Billion |
| Date of Birth: | 1928 |
| Gender: | Male |
| Nationality: | United States of America |